A new trading day began on Monday, with Upstream Bio Inc (NASDAQ: UPB) stock price up 3.69% from the previous day of trading, before settling in for the closing price of $16.0. UPB’s price has ranged from $5.14 to $29.46 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 50.04%. With a float of $19.41 million, this company’s outstanding shares have now reached $53.80 million.
The extent of productivity of a business whose workforce counts for 52 workers is very important to gauge. In terms of profitability, gross margin is 100.0%, operating margin of -4464.6%, and the pretax margin is -3836.58%.
Upstream Bio Inc (UPB) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Upstream Bio Inc is 63.99%, while institutional ownership is 48.90%. The most recent insider transaction that took place on Oct 15 ’24, was worth 14,025,000. In this transaction Director of this company bought 825,000 shares at a rate of $17.00, taking the stock ownership to the 4,554,873 shares. Before that another transaction happened on Oct 15 ’24, when Company’s Director bought 825,000 for $17.00, making the entire transaction worth $14,025,000. This insider now owns 4,554,873 shares in total.
Upstream Bio Inc (UPB) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -6.96 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.77 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.04% per share during the next fiscal year.
Upstream Bio Inc (NASDAQ: UPB) Trading Performance Indicators
Here are Upstream Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 38.27. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 328.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.05, a number that is poised to hit -0.77 in the next quarter and is forecasted to reach -2.98 in one year’s time.
Technical Analysis of Upstream Bio Inc (UPB)
The latest stats from [Upstream Bio Inc, UPB] show that its last 5-days average volume of 0.55 million was superior to 0.35 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 67.05%.
During the past 100 days, Upstream Bio Inc’s (UPB) raw stochastic average was set at 92.11%, which indicates a significant increase from 85.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.32 in the past 14 days, which was higher than the 0.87 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.12, while its 200-day Moving Average is $13.02. Now, the first resistance to watch is $16.93. This is followed by the second major resistance level at $17.26. The third major resistance level sits at $17.91. If the price goes on to break the first support level at $15.95, it is likely to go to the next support level at $15.30. The third support level lies at $14.97 if the price breaches the second support level.
Upstream Bio Inc (NASDAQ: UPB) Key Stats
With a market capitalization of 894.36 million, the company has a total of 53,794K Shares Outstanding. Currently, annual sales are 2,370 K while annual income is -62,810 K. The company’s previous quarter sales were 570 K while its latest quarter income was -27,270 K.
